nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—IMPA2—parotid gland—salivary gland cancer	0.0201	0.117	CbGeAlD
Lithium—IMPA2—saliva-secreting gland—salivary gland cancer	0.0193	0.112	CbGeAlD
Lithium—GSK3B—connective tissue—salivary gland cancer	0.0174	0.101	CbGeAlD
Lithium—IMPA1—lymphoid tissue—salivary gland cancer	0.0172	0.1	CbGeAlD
Lithium—GSK3A—parotid gland—salivary gland cancer	0.0172	0.0994	CbGeAlD
Lithium—GSK3B—epithelium—salivary gland cancer	0.0165	0.0955	CbGeAlD
Lithium—GSK3A—saliva-secreting gland—salivary gland cancer	0.0164	0.0952	CbGeAlD
Lithium—GSK3A—connective tissue—salivary gland cancer	0.0151	0.0875	CbGeAlD
Lithium—GSK3B—lymphoid tissue—salivary gland cancer	0.0127	0.0736	CbGeAlD
Lithium—IMPA2—lymph node—salivary gland cancer	0.0073	0.0423	CbGeAlD
Lithium—GSK3B—lymph node—salivary gland cancer	0.00716	0.0415	CbGeAlD
Lithium—GSK3A—lymph node—salivary gland cancer	0.00623	0.0361	CbGeAlD
Lithium—GSK3B—Downstream signal transduction—PTEN—salivary gland cancer	0.000302	0.000365	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.000302	0.000364	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—PTEN—salivary gland cancer	0.0003	0.000363	CbGpPWpGaD
Lithium—GSK3B—Role of LAT2/NTAL/LAB on calcium mobilization—PIK3CA—salivary gland cancer	0.0003	0.000362	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—PTEN—salivary gland cancer	0.000299	0.000361	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—CREBBP—salivary gland cancer	0.000298	0.00036	CbGpPWpGaD
Lithium—GSK3A—Disease—FGF16—salivary gland cancer	0.000298	0.00036	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—PTEN—salivary gland cancer	0.000297	0.000359	CbGpPWpGaD
Lithium—GSK3B—Wnt Signaling Pathway and Pluripotency—TP53—salivary gland cancer	0.000297	0.000358	CbGpPWpGaD
Lithium—GSK3B—Cell Cycle—TP53—salivary gland cancer	0.000297	0.000358	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—HRAS—salivary gland cancer	0.000296	0.000358	CbGpPWpGaD
Lithium—GSK3B—B Cell Receptor Signaling Pathway—HRAS—salivary gland cancer	0.000295	0.000357	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.000293	0.000354	CbGpPWpGaD
Lithium—GSK3B—Disease—ST3GAL4—salivary gland cancer	0.000293	0.000354	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—PTEN—salivary gland cancer	0.000293	0.000354	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—PIK3CA—salivary gland cancer	0.000291	0.000351	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FGFR4—salivary gland cancer	0.00029	0.000351	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—TP53—salivary gland cancer	0.00029	0.00035	CbGpPWpGaD
Lithium—GSK3A—Insulin Signaling—PIK3CA—salivary gland cancer	0.000289	0.00035	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MC3R—salivary gland cancer	0.000288	0.000349	CbGpPWpGaD
Lithium—GSK3B—Immune System—DTX4—salivary gland cancer	0.000288	0.000348	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—PIK3CA—salivary gland cancer	0.000288	0.000348	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—PIK3CA—salivary gland cancer	0.000287	0.000346	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FBXW7—salivary gland cancer	0.000286	0.000345	CbGpPWpGaD
Lithium—GSK3A—Disease—NUP62—salivary gland cancer	0.000286	0.000345	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—PIK3CA—salivary gland cancer	0.000285	0.000345	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—CREBBP—salivary gland cancer	0.000284	0.000344	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—FOXO3—salivary gland cancer	0.000284	0.000343	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—PIK3CA—salivary gland cancer	0.000284	0.000343	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—HRAS—salivary gland cancer	0.000283	0.000343	CbGpPWpGaD
Lithium—GSK3A—Disease—VCAN—salivary gland cancer	0.000283	0.000342	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—TP53—salivary gland cancer	0.000281	0.00034	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—salivary gland cancer	0.00028	0.000338	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—PTEN—salivary gland cancer	0.00028	0.000338	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—PTEN—salivary gland cancer	0.00028	0.000338	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—PTEN—salivary gland cancer	0.00028	0.000338	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—HRAS—salivary gland cancer	0.000279	0.000337	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000278	0.000336	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—HRAS—salivary gland cancer	0.000277	0.000335	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—MAP2K2—salivary gland cancer	0.000277	0.000335	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—PTEN—salivary gland cancer	0.000277	0.000335	CbGpPWpGaD
Lithium—IMPA2—Metabolism—CREBBP—salivary gland cancer	0.000276	0.000334	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—PTEN—salivary gland cancer	0.000275	0.000332	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—CCND1—salivary gland cancer	0.000274	0.000331	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—PTEN—salivary gland cancer	0.000273	0.00033	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—WNT5B—salivary gland cancer	0.000271	0.000327	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—HRAS—salivary gland cancer	0.000269	0.000325	CbGpPWpGaD
Lithium—GSK3A—Insulin Signaling—HRAS—salivary gland cancer	0.000268	0.000324	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—PIK3CA—salivary gland cancer	0.000267	0.000323	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	0.000267	0.000323	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—PIK3CA—salivary gland cancer	0.000267	0.000323	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—HRAS—salivary gland cancer	0.000266	0.000322	CbGpPWpGaD
Lithium—GSK3B—Disease—DTX4—salivary gland cancer	0.000266	0.000322	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—HRAS—salivary gland cancer	0.000265	0.00032	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—PIK3CA—salivary gland cancer	0.000265	0.00032	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—PTEN—salivary gland cancer	0.000264	0.000319	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—HRAS—salivary gland cancer	0.000264	0.000319	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—HRAS—salivary gland cancer	0.000263	0.000317	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—PIK3CA—salivary gland cancer	0.000262	0.000317	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL17RD—salivary gland cancer	0.000261	0.000316	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—PIK3CA—salivary gland cancer	0.000261	0.000316	CbGpPWpGaD
Lithium—GSK3B—Immune System—CYLD—salivary gland cancer	0.000261	0.000315	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—PTEN—salivary gland cancer	0.000259	0.000313	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—HRAS—salivary gland cancer	0.000259	0.000313	CbGpPWpGaD
Lithium—GSK3A—Disease—MAML2—salivary gland cancer	0.000259	0.000313	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—PTEN—salivary gland cancer	0.000258	0.000312	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—PTEN—salivary gland cancer	0.000253	0.000305	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DTX4—salivary gland cancer	0.000252	0.000305	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000251	0.000304	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—FOXO3—salivary gland cancer	0.000251	0.000303	CbGpPWpGaD
Lithium—GSK3B—Immune System—PRKDC—salivary gland cancer	0.00025	0.000302	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—PTEN—salivary gland cancer	0.000248	0.000299	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—PIK3CA—salivary gland cancer	0.000247	0.000299	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—HRAS—salivary gland cancer	0.000247	0.000299	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—HRAS—salivary gland cancer	0.000247	0.000299	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	0.000247	0.000299	CbGpPWpGaD
Lithium—IMPA1—Metabolism—CREBBP—salivary gland cancer	0.000246	0.000298	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—CREBBP—salivary gland cancer	0.000246	0.000297	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—HRAS—salivary gland cancer	0.000245	0.000296	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000243	0.000294	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—HRAS—salivary gland cancer	0.000243	0.000293	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—HRAS—salivary gland cancer	0.000242	0.000292	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—EP300—salivary gland cancer	0.000241	0.000291	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FOXO3—salivary gland cancer	0.000241	0.000291	CbGpPWpGaD
Lithium—GRIA3—Neuronal System—HRAS—salivary gland cancer	0.000239	0.000289	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAML3—salivary gland cancer	0.000239	0.000289	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGF16—salivary gland cancer	0.000238	0.000288	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGFR4—salivary gland cancer	0.000238	0.000288	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—PIK3CA—salivary gland cancer	0.000237	0.000286	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000236	0.000286	CbGpPWpGaD
Lithium—GSK3A—Immune System—FBXW7—salivary gland cancer	0.000234	0.000283	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—MAP2K2—salivary gland cancer	0.000232	0.00028	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—HRAS—salivary gland cancer	0.000229	0.000276	CbGpPWpGaD
Lithium—GSK3B—Immune System—NUP62—salivary gland cancer	0.000229	0.000276	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—PIK3CA—salivary gland cancer	0.000226	0.000274	CbGpPWpGaD
Lithium—GSK3B—TCF dependent signaling in response to WNT—EP300—salivary gland cancer	0.000226	0.000273	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.000223	0.000269	CbGpPWpGaD
Lithium—GSK3A—Disease—JAG1—salivary gland cancer	0.000221	0.000267	CbGpPWpGaD
Lithium—GSK3B—Disease—FGF16—salivary gland cancer	0.00022	0.000266	CbGpPWpGaD
Lithium—GSK3A—Disease—FGFR4—salivary gland cancer	0.00022	0.000266	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—HRAS—salivary gland cancer	0.000219	0.000265	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000219	0.000264	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—EP300—salivary gland cancer	0.000219	0.000264	CbGpPWpGaD
Lithium—GSK3A—Disease—FBXW7—salivary gland cancer	0.000216	0.000262	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—HRAS—salivary gland cancer	0.000215	0.00026	CbGpPWpGaD
Lithium—GSK3B—Insulin Signaling—PIK3CA—salivary gland cancer	0.000214	0.000258	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MC3R—salivary gland cancer	0.000213	0.000258	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—PIK3CA—salivary gland cancer	0.000213	0.000257	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—PIK3CA—salivary gland cancer	0.000212	0.000256	CbGpPWpGaD
Lithium—GSK3B—Disease—NUP62—salivary gland cancer	0.000211	0.000255	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—PIK3CA—salivary gland cancer	0.000211	0.000255	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—PIK3CA—salivary gland cancer	0.00021	0.000253	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—HRAS—salivary gland cancer	0.000209	0.000253	CbGpPWpGaD
Lithium—GSK3B—Disease—VCAN—salivary gland cancer	0.000209	0.000253	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGF16—salivary gland cancer	0.000209	0.000252	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—salivary gland cancer	0.000207	0.00025	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—HRAS—salivary gland cancer	0.000206	0.000249	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CREBBP—salivary gland cancer	0.000206	0.000249	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000205	0.000248	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MAP2K2—salivary gland cancer	0.000205	0.000248	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—EP300—salivary gland cancer	0.000203	0.000245	CbGpPWpGaD
Lithium—GSK3B—Insulin Signaling—HRAS—salivary gland cancer	0.000198	0.000239	CbGpPWpGaD
Lithium—GSK3A—Immune System—FOXO3—salivary gland cancer	0.000198	0.000239	CbGpPWpGaD
Lithium—IMPA2—Metabolism—PTEN—salivary gland cancer	0.000197	0.000238	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—PIK3CA—salivary gland cancer	0.000197	0.000238	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—PIK3CA—salivary gland cancer	0.000197	0.000238	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	0.000197	0.000238	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—HRAS—salivary gland cancer	0.000197	0.000238	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CDH1—salivary gland cancer	0.000196	0.000237	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—HRAS—salivary gland cancer	0.000196	0.000237	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—PIK3CA—salivary gland cancer	0.000196	0.000236	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—HRAS—salivary gland cancer	0.000195	0.000236	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—HRAS—salivary gland cancer	0.000194	0.000234	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—PIK3CA—salivary gland cancer	0.000194	0.000234	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—EP300—salivary gland cancer	0.000194	0.000234	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—PIK3CA—salivary gland cancer	0.000193	0.000233	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—HRAS—salivary gland cancer	0.000191	0.000231	CbGpPWpGaD
Lithium—GSK3B—Disease—MAML2—salivary gland cancer	0.000191	0.000231	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—PTEN—salivary gland cancer	0.000191	0.00023	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—NOTCH1—salivary gland cancer	0.00019	0.00023	CbGpPWpGaD
Lithium—IMPA2—Metabolism—EP300—salivary gland cancer	0.000188	0.000227	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—PIK3CA—salivary gland cancer	0.000186	0.000225	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DTX4—salivary gland cancer	0.000186	0.000225	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—PIK3CA—salivary gland cancer	0.000183	0.000221	CbGpPWpGaD
Lithium—GSK3A—Disease—FOXO3—salivary gland cancer	0.000183	0.000221	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	0.000183	0.000221	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—HRAS—salivary gland cancer	0.000183	0.000221	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—HRAS—salivary gland cancer	0.000183	0.000221	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—PIK3CA—salivary gland cancer	0.000182	0.00022	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAML2—salivary gland cancer	0.000181	0.000219	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—HRAS—salivary gland cancer	0.000181	0.000219	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—HRAS—salivary gland cancer	0.000179	0.000217	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—HRAS—salivary gland cancer	0.000179	0.000216	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGFR4—salivary gland cancer	0.000176	0.000213	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PTEN—salivary gland cancer	0.000176	0.000213	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000175	0.000211	CbGpPWpGaD
Lithium—GSK3B—Immune System—FBXW7—salivary gland cancer	0.000173	0.000209	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—HRAS—salivary gland cancer	0.000172	0.000208	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—TP53—salivary gland cancer	0.000172	0.000208	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—CREBBP—salivary gland cancer	0.000172	0.000208	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—HRAS—salivary gland cancer	0.000169	0.000204	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—HRAS—salivary gland cancer	0.000168	0.000203	CbGpPWpGaD
Lithium—IMPA1—Metabolism—EP300—salivary gland cancer	0.000168	0.000203	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—EP300—salivary gland cancer	0.000167	0.000202	CbGpPWpGaD
Lithium—GSK3B—Disease—JAG1—salivary gland cancer	0.000163	0.000197	CbGpPWpGaD
Lithium—GSK3B—Disease—FGFR4—salivary gland cancer	0.000163	0.000196	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000162	0.000195	CbGpPWpGaD
Lithium—GSK3A—Immune System—MAP2K2—salivary gland cancer	0.000161	0.000195	CbGpPWpGaD
Lithium—GSK3B—Disease—FBXW7—salivary gland cancer	0.00016	0.000193	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—JAG1—salivary gland cancer	0.000155	0.000187	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGF16—salivary gland cancer	0.000154	0.000186	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGFR4—salivary gland cancer	0.000154	0.000186	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CREBBP—salivary gland cancer	0.000152	0.000184	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FBXW7—salivary gland cancer	0.000152	0.000183	CbGpPWpGaD
Lithium—GSK3A—Disease—MAP2K2—salivary gland cancer	0.000149	0.00018	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—PTEN—salivary gland cancer	0.000147	0.000178	CbGpPWpGaD
Lithium—GSK3B—Immune System—FOXO3—salivary gland cancer	0.000146	0.000177	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CDH1—salivary gland cancer	0.000145	0.000175	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—PTEN—salivary gland cancer	0.000141	0.000171	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—EP300—salivary gland cancer	0.00014	0.000169	CbGpPWpGaD
Lithium—IMPA2—Metabolism—PIK3CA—salivary gland cancer	0.000139	0.000168	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—TP53—salivary gland cancer	0.000139	0.000168	CbGpPWpGaD
Lithium—GSK3B—Disease—FOXO3—salivary gland cancer	0.000135	0.000163	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—PIK3CA—salivary gland cancer	0.000134	0.000162	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAML2—salivary gland cancer	0.000134	0.000162	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FOXO3—salivary gland cancer	0.000128	0.000154	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—HRAS—salivary gland cancer	0.000124	0.00015	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PIK3CA—salivary gland cancer	0.000124	0.00015	CbGpPWpGaD
Lithium—GSK3A—Disease—NOTCH1—salivary gland cancer	0.000122	0.000148	CbGpPWpGaD
Lithium—GSK3A—Immune System—CREBBP—salivary gland cancer	0.00012	0.000145	CbGpPWpGaD
Lithium—GSK3B—Immune System—MAP2K2—salivary gland cancer	0.000119	0.000144	CbGpPWpGaD
Lithium—GSK3A—Immune System—CDH1—salivary gland cancer	0.000119	0.000144	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—EP300—salivary gland cancer	0.000117	0.000142	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—JAG1—salivary gland cancer	0.000114	0.000138	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGFR4—salivary gland cancer	0.000114	0.000138	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—HRAS—salivary gland cancer	0.000113	0.000136	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FBXW7—salivary gland cancer	0.000112	0.000135	CbGpPWpGaD
Lithium—GSK3A—Disease—CREBBP—salivary gland cancer	0.000111	0.000134	CbGpPWpGaD
Lithium—GSK3B—Disease—MAP2K2—salivary gland cancer	0.00011	0.000133	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—PTEN—salivary gland cancer	0.000109	0.000131	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000104	0.000126	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—PTEN—salivary gland cancer	0.000104	0.000126	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—PIK3CA—salivary gland cancer	0.000104	0.000125	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—EP300—salivary gland cancer	0.000104	0.000125	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—PIK3CA—salivary gland cancer	9.96e-05	0.00012	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—HRAS—salivary gland cancer	9.6e-05	0.000116	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FOXO3—salivary gland cancer	9.45e-05	0.000114	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—HRAS—salivary gland cancer	9.22e-05	0.000111	CbGpPWpGaD
Lithium—GSK3B—Disease—NOTCH1—salivary gland cancer	9.02e-05	0.000109	CbGpPWpGaD
Lithium—GSK3B—Immune System—CREBBP—salivary gland cancer	8.86e-05	0.000107	CbGpPWpGaD
Lithium—GSK3B—Immune System—CDH1—salivary gland cancer	8.8e-05	0.000106	CbGpPWpGaD
Lithium—GSK3A—Immune System—PTEN—salivary gland cancer	8.56e-05	0.000103	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NOTCH1—salivary gland cancer	8.55e-05	0.000103	CbGpPWpGaD
Lithium—GSK3B—Disease—CREBBP—salivary gland cancer	8.18e-05	9.89e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—EP300—salivary gland cancer	8.17e-05	9.87e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—HRAS—salivary gland cancer	8.03e-05	9.7e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—PTEN—salivary gland cancer	7.91e-05	9.56e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CREBBP—salivary gland cancer	7.75e-05	9.37e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAP2K2—salivary gland cancer	7.71e-05	9.32e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—PIK3CA—salivary gland cancer	7.67e-05	9.26e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—EP300—salivary gland cancer	7.54e-05	9.11e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—PIK3CA—salivary gland cancer	7.36e-05	8.9e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—HRAS—salivary gland cancer	7.09e-05	8.57e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HRAS—salivary gland cancer	6.81e-05	8.23e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PTEN—salivary gland cancer	6.33e-05	7.65e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOTCH1—salivary gland cancer	6.32e-05	7.64e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—PIK3CA—salivary gland cancer	6.04e-05	7.3e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—EP300—salivary gland cancer	6.04e-05	7.29e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PTEN—salivary gland cancer	5.84e-05	7.06e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCND1—salivary gland cancer	5.74e-05	6.93e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CREBBP—salivary gland cancer	5.73e-05	6.92e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—HRAS—salivary gland cancer	5.59e-05	6.76e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—PIK3CA—salivary gland cancer	5.58e-05	6.74e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—EP300—salivary gland cancer	5.57e-05	6.73e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PTEN—salivary gland cancer	5.54e-05	6.69e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—EP300—salivary gland cancer	5.28e-05	6.38e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—HRAS—salivary gland cancer	5.16e-05	6.24e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PIK3CA—salivary gland cancer	4.46e-05	5.4e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCND1—salivary gland cancer	4.24e-05	5.12e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—HRAS—salivary gland cancer	4.13e-05	4.99e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PIK3CA—salivary gland cancer	4.12e-05	4.98e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTEN—salivary gland cancer	4.09e-05	4.94e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PIK3CA—salivary gland cancer	3.91e-05	4.72e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—EP300—salivary gland cancer	3.9e-05	4.72e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—HRAS—salivary gland cancer	3.81e-05	4.61e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TP53—salivary gland cancer	3.78e-05	4.57e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HRAS—salivary gland cancer	3.61e-05	4.37e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PIK3CA—salivary gland cancer	2.89e-05	3.49e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TP53—salivary gland cancer	2.79e-05	3.37e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HRAS—salivary gland cancer	2.67e-05	3.23e-05	CbGpPWpGaD
